Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Pharmaceutical Particle Engineering via Spray Drying
2007 Standout
Pharmacotherapy of type 2 diabetes: An update
2017
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease
2005 StandoutNobel
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
1998 Standout
Low-dose acetylsalicylic acid (ASA) plus dipyridamole versus dipyridamole alone in the prevention of stroke in patients with reversible ischemic attacks
1987
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study
1995 Standout
Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
2014
Antithrombotic Therapy for VTE Disease
2012 Standout
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Type 2 diabetes
2017 Standout
Characterization of Prostaglandin H Synthase 2 Deficient Mice and Implications for Mechanisms of NSAID Action
1997 StandoutNobel
Type 2 Diabetes Mellitus: A Review of Current Trends
2012
Nonsteroidal Antiinflammatory Drugs — Differences and Similarities
1991
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
Randomized comparative trial of triflusal and aspirin following acute myocardial infarction
2000
Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial
2001 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
1998 Standout
New Insulins and New Aspects in Insulin Delivery
2015
The “Vertigo” of the Food Sector within the Triangle of Climate Change, the Post-Pandemic World, and the Russian-Ukrainian War
2023 Standout
Pulmonary Insulin Delivery—State of the Art 2007
2007
Recent Advances in Insulin Therapy
2020
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Dietary exposure assessment to perchlorate in the European population
2017
Overview of the activities of the European Food Safety Authority on mycotoxins in food and feed
2018
The Current State of Peptide Drug Discovery: Back to the Future?
2017
Phenolics and polyphenolics in foods, beverages and spices: Antioxidant activity and health effects – A review
2015 Standout
Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events
1991
'Human' insulin versus animal insulin in people with diabetes mellitus
2005
Increasing the utilisation of sorghum, millets and pseudocereals: Developments in the science of their phenolic phytochemicals, biofortification and protein functionality
2013
The Effects of Cadmium Toxicity
2020 Standout
A meta-analysis of randomized controlled trials
2019 Standout
State of the art review of Big Data and web-based Decision Support Systems (DSS) for food safety risk assessment with respect to climate change
2021
Worldwide contamination of food-crops with mycotoxins: Validity of the widely cited ‘FAO estimate’ of 25%
2019 Standout
Danish very-low-dose aspirin after carotid endarterectomy trial.
1988
Human Placental Transfer of the Prostaglandin Inhibitor Sulindac Using an In Vitro Model
1995
Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2
2001 StandoutNobel
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Effects of non‐steroidal anti‐inflammatory drugs on prostacyclin and thromboxane biosynthesis in patients with mild essential hypertension.
1990
Works of Anders Boss being referenced
Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial
2011
Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial
2010
Technosphere ® Insulin Technology
2007
Technosphere Insulin Effectively Controls Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus
2012
Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin
2016
Safe changeover to Human Protaphane from porcine Semitard MC insulin
1989
Prolongation of bleeding time and inhibition of platelet aggregation by low-dose acetylsalicylic acid in patients with cerebrovascular disease.
1984
Bleeding time, thromboxane production and platelet aggregation in stepwise increment of acetylsalicylic acid
2009
Coverage of Postprandial Blood Glucose Excursions With Inhaled Technosphere Insulin in Comparison to Subcutaneously Injected Regular Human Insulin in Subjects With Type 2 Diabetes
2007
Randomized Forced Titration to Different Doses of Technosphere® Insulin Demonstrates Reduction in Postprandial Glucose Excursions and Hemoglobin A1c in Patients with Type 2 Diabetes
2008
Effect of incremental doses of aspirin on bleeding time, platelet aggregation and thromboxane production in patients with cerebrovascular disease
1985
Effects of sulindac on renal and extrarenal eicosanoid synthesis
1987
Methodological characteristics of the national dietary surveys carried out in the European Union as included in the European Food Safety Authority (EFSA) Comprehensive European Food Consumption Database
2011